Table 1.

Articles on EDCs and endometrial cancer published until 2016.

Type of Article	Main Author (Year)	Subject
Review	Klinge (2015) [18]	miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.
Review	Gibson (2015) [9]	Endocrine disruption of oestrogen action and female reproductive tract cancers.
Review	Rochester (2015) [19]	Bisphenol A and human health: A review of the literature
In vitro study	Nordeen (2013) [20]	Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin
In vitro study	Kortenkamp (2011) [21]	Are cadmium and other heavy metal compounds acting as endocrine disrupters?
In vitro study	Boehme (2009) [22]	Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds
In vitro study	Xu (2008) [23]	Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors.
Review	Caserta (2008) [24]	Impact of endocrine disruptor chemicals in gynaecology.
In vitro study	Singleton (2006) [25]	Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-alpha-positive human cells.
Case Control Study	Hardell (2004) [26]	Adipose tissue concentrations of p,p’-DDE and the risk for endometrial cancer.
In vitro study	Safe (1998) [27]	Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms.
In vitro study	Garey (1998) [28]	Estrogenic and antiprogestagenic activities of pyrethroid insecticides.